Green Chemistry
Page 10 of 12
were concentrated on a rotary evaporator to afford the crude product. The
as
3
crude product was recrystallized from aq EtOH to afford 5 (18.3 g, 95%)
white solid.18a The cotton plug retaining the recovered catalyst was put in
a rb flask (20 mL) and dried under rotary vacuum evaporation when the
catalyst separated out from the cotton (720 mg, 90%). The catalyst was
activated by heating under reduced pressure (10 mm Hg) at 80 °C for 24 105
h. The reaction was repeated at 40 mmol, 30 mmol, 20 mmol and 10
mmol scales the in presence of the recovered HBF4-SiO2 (0.5 g, 0.25 g,
10 0.12 g and 0.05 g, respectively) to afford 5 in 14.6 g (95 %), 10.3 g (89
%), 6.8 g (88 %), and 3.2 g (85 %), respectively as white solid identical
(spectral data) with an authentic sample.
Laydon, D. E. Griswold, M. C. Chabot-Fletcher, J. J. Breton and J. L.
Adams, Bioorg. Med. Chem. Lett. 1995, 5, 1171.
5
T. F. Gallagher, G. L. Seibel, S. Kassis, J. T. Laydon, m. J.
Blumenthal, J. C Lee, D. Lee, J. C. Boehm, S. M. Fier-Thompson, A.
W. Abt, M. E. Sorenson, J. M. Smietana, R. F. Hall, R. S. Garigipati,
P. E. Bender, K. F. Erhard, A. J. Krog, G. A. Hofmann, P. L.
Sheldrake, P. C. McDonnell, S. Kumar, P. R. Young and J. L.
Adams, Bioorg. Med. Chem. 1997, 5, 49.
M. Antolini, A. Bozzoli, C. Ghiron, G. Kennedy, T. Rossi and A.
Ursini, Bioorg. Med. Chem. Lett. 1999, 9, 1023.
S. E. de Laszlo, C. Hacker, B. Li, D. Kim, M. MacCoss, N. Mantlo,
J. V. Pivnichny, L. Colwell, G. E. Koch, M. A. Cascieri and W. K.
Hagmann, Bioorg. Med. Chem. Lett. 1999, 9, 641.
a) N. J. Liverton, j. W. Butcher, C. F. Claiborne, D. A. Claremon, B.
E. Libby, K. T. Nguyen, S. M. Pitzenberger, H. G. Selnick, G. R.
Smith, A. Tebben, J. P. Vacca, S. L. Varga, L. Agarwal, K.
Dancheck, A. J. Forsyth, D. S. Fletcher, B. Frantz, W. A. Hanlon, C,
F. Harper, S. J. Hofsess, M. Kostura, J. Lin, S. Luell, E. A. O’neill,
C. J. Orevillo, M. Pang, J. Parsons, A. Rolando, Y. Sahly, D. M.
Visco and S. J. O’Keefe, J. Med. Chem. 1999, 42, 2180; b) L.
Revesz, E. Blum, F. E. D. Padova, T. Buhl, R. Feifel, H. Gram, P.
Hiestand, U. Manning and G. Rucklin, Bioorg. Med. Chem. Lett.
2004, 14, 3595; c) M. Mader, A. De dios, C. Shih, R. Bonjouklian, T.
Li, W. White, B. L. De Uralde, C. Sánchez-Martinez, M. Del Prado,
C. Jaramillo, E. De Diego, L. M. M. Cabrejas, C. Dominguez, C.
Montero, T. Shepherd, R. Dally, J. E. Toth, A. Chatterjee, S. Pleite, J.
Blanco-Urgoiti, L. Perez, M. Barberis, M. J. Lorite, E. Jambrina, C.
R. Nevill Jr., P. A. Lee, R. C. Schultz, J. A. Wolos, L. C. Li, R. M.
Campbell and B. D. Anderson, Bioorg. Med. Chem. Lett. 2008, 18,
179.
a) M. J. Newman, J. C. Rodarte, K. D. Benbatoul, S. J. Romano, C.
Zhang, S. Krane, E. J. Moran, R. T. Uyeda, R. Dixon, E. S. Guns and
L. D. Mayer, Cancer Res. 2000, 60, 2964; b) S. Sarshar, C. Zhang, E.
J. Moran, S. Krane, J. C. Rodarte, K. D. Benbatoul, R. Dixon, A. M.
M. Mjalli, Bioorg. Med. Chem. Lett. 2000, 10, 2599; c) C. Zhang, S.
Sarshar, E. J. Moran, S. Krane, J. C. Rodarte, K. D. Benbatoul, R.
Dixon, A. M. M. Mjalli, Bioorg. Med. Chem. Lett. 2000, 10, 2603.
P. Deprez, E. Mandine, A. Vermond and D. Lesuisse, Bioorg. Med.
Chem. Lett. 2002, 12, 1287.
90
4
5
The physical data (IR, NMR and MS) of new compounds are provided
below.
15 1-(4-Chlorobenzyl)-2-(4-chlorophenyl)-4,5-diphenyl-1H-imidazole
(Table 11, Entry 6) White Solid (1.0 g, 95 % ), m.p. 177-178 °C. IR
(KBr)
= 3420, 3006, 1606, 1483, 1275, 1092, 832, 764 cm-1. 1H 170
6
max
NMR (400 MHz, CDCl3): δ = 7.53-7.58 (m, 4 H ArH), 7.31-7.40 (m, 5 H,
ArH), 7.12-7.24 (m, 7 H, ArH), 6.7 (d, J = 8.4 Hz, 2 H, ArH), 5.04 (s, 3
20 H, PhCH2). 13C NMR (100 MHz, CDCl3): δ = 146.8, 138.4, 135.7, 134.1,
133.4, 130.9, 130.6, 130.2, 130.2, 130.1, 129.2, 129.0, 128.9, 128.5,
128.9, 128.2, 127.3, 126.8, 126.6, 47.7. HRMS (ESI) m/z calcd for 175
C28H20Cl2N2Na+ [M + Na+], 477.0896; Found 477.0894.
1-(4-Methoxy-2-hydroxybenzyl)-2-(4-dimethylaminophenyl)-4,5-
25 diphenyl-1H-imidazole (Table 11, Entry 7) White Solid (0.97 g, 82 % ),
m.p. 271-272 °C. IR (KBr)
= 3430, 2994, 1610, 1396, 1280, 834,
max
776 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.50 (m, 2 H ArH), 7.45(d, J 180
= 8.8 Hz, 2 H, ArH), 7.24 (m, 1 H, ArH), 7.08-7.18 (m, 5 H, ArH), 6.65
(d, J = 7.2 Hz, 2 H, ArH), 6.60 (t, J = 6.3 Hz, 2 H, ArH), 6.54 (d, J = 8.8
30 Hz, 2 H, ArH), 6.12-6.15 (m, 1 H, ArH), 6.12 (s, 2 H, CH2), 3.85 (s, 3 H,
OCH3), 2.88 (s, 6 H, CH3). 13C NMR (100 MHz, CDCl3): δ = 150.6,
148.2, 146.4, 146.2, 131.1, 129.9, 129.5, 128.5, 128.3, 128.0, 126.8, 185
117.0, 116.2, 115.2, 112.5, 112.0, 110.9, 56.0, 47.8, 40.2. HRMS (ESI)
m/z calcd for C31H29N3O2Na+ [M + Na+], 498.2152; Found 498.2164.
35 4-(2-(2-(4-methoxyphenyl)-4,5-diphenyl-1H-imidazol-1-
7
yl)ethyl)morpholine (Table 7, Entry 12) White Solid (0.9 g, 88 %), IR
(KBr)
= 3420, 2896, 1625, 1385, 1280, 766 cm-1. 1H NMR (400 140
max
MHz, CDCl3): δ = 7.62-7.66 (m, 2 H, ArH), 7.51-7.53 (m, 2 H, ArH),
7.41-7.48 (m, 5 H, ArH), 7.17-7.21 (m, 2 H, ArH), 7.10 (m, 1 H, ArH),
40 6.98-7.02 (m, 2 H, ArH), 4.00 (t, J = 7.32 Hz, 2 H, CH2), 3.85 (s, 3 H,
OCH3), 3.48 (t, J = 4.60 Hz, 4 H, CH2), 2.23 (t, J = 7.16 Hz, 2 H, CH2),
2.04 (t, J = 4.52 Hz, 4 H, CH2). 13C NMR (100 MHz, CDCl3): δ = 160.1, 120
147.8, 137.5, 134.5, 131.5, 131.0, 130.6, 129.2, 129.1, 128.7, 128.4,
126.8, 126.2, 123.7, 114.0, 66.7, 58.2, 55.4, 53.4, 41.8. HRMS (ESI) m/z
45 calcd for C28H29N3O2Na+ [M + Na+], 462.2152; Found 462.2164.
1-(4-Methoxyphenyl)-2-(4-dimethylaminophenyl)-4,5-diphenyl-1H-
imidazole (Table 11, Entry 15) white solid (1.0 g, 90 %), IR (KBr)
max = 3425, 2982, 1625, 1390, 1282, 847, 745 cm-1. 1H NMR (400 MHz,
CDCl3): δ = 7.60-7.62 (m, 2 H, ArH), 7.33-7.35 (m, 2 H, ArH), 7.12-7.27
50 (m, 8 H, ArH), 6.97-7.70 (m, 2 H, ArH), 6.76-6.80 (m, 2 H, ArH), 6.57-
6.60 (m, 2 H, ArH), 3.79 (s, 3 H, OCH3), 2.94 (s, 6 H, CH3). 13C NMR
(100 MHz, CDCl3): δ = 158.9, 150.0, 147.7, 137.6, 134.8, 131.2, 131.1, 140
130.4, 130.3, 129.8, 129.7, 128.2, 128.0, 127.6, 127.4, 126.3, 118.4,
114.1, 111.5, 55.3, 40.2. HRMS (ESI) m/z calcd for C30H27N3ONa+ [M +
55 Na+], 468.2046; Found 468.2046.
8
9
L. Wang, K. W. Woods, Q. Li, K. J. Barr, R. W. McCroskey, S. M.
Hannick, L. Gherke, R. B. Credo, Y. H. Hui, K. Marsh, R. Warner, J.
Y. Lee, N. Zielinsky- Mozng, D. Frost, S. H. Rosenberg and H. L.
Sham, J. Med. Chem. 2002, 45, 1697.
130 10 D. S. Weinstein, W. Liu, K. Ngu, C. Langevine, D. W. Combs, S.
Zhuang, C. Chen C. S. Madsen, T. W. Harper, J. A. Robl Bioorg.
Med. Chem. Lett. 2007, 17, 5115.
11 J. H. M. Lange, H. H. Van Stuivenberg, H. K. A. C. Coolen, T. J. P.
Adolfs, A. C. McCreary, H. G. Keizer, H. C. Wals, W. Veerman, A.
J. M. Borst, W. de Looff, P. C.Verveer and C. G Kruse, J. Med.
Chem. 2005, 48, 1823.
12 A. K. Takle, M. J. B. Brown, S. Davies, D. K. Dean, G. Francis, A.
Gaiba, A. W. Hird, F. D. King, P. J. Lovell, A. Naylor, A. D. Reith,
J. G. Steadman and D. M. Wilson, Bioorg. Med. Chem. Lett. 2006,
2-(4-Chlorophenyl)-1-cyclohexyl-4,5-diphenyl-1H-imidazole (Table
11, Entry 17) White solid (1.0 g, 80 %), IR (KBr)
= 3746, 3449, 145
16, 378.
max
2925, 1747, 1447, 1366, 1275, 1216, 1091, 750 cm-1. 1H NMR (400 MHz,
CDCl3): δ = 7.54-7.58 (m, 2 H, ArH), 7.39-7.48 (m, 9 H, ArH), 7.06-7.16
60 (m, 3 H, ArH), 3.88-3.95 (m, 1H, cyCH), 1.62-1.85 (m, 4 H, cyCH2),
1.42-1.58 (m, 3 H, cyCH2), 0.99-1.10 (m, 2 H, cyCH2), 0.79 (m, 1 H,
cyCH2). 13C NMR (100 MHz, CDCl3): δ = 146.4, 138.0, 135.0, 134.4, 175
132.3, 132.1, 131.3, 130.9, 129.4, 128.9, 128.7, 128.6, 127.9, 126.6,
126.1, 58.4, 33.6, 26.2, 25.0. HRMS (ESI) m/z calcd for C27H25ClN2H+
65 [M + H+], 413.1779; Found 413.1790.
13 a) J. Wang, R. Mason, D. V. Derveer, K. Feng and X. R. Bu, J. Org.
Chem. 2003, 68, 5415; b) S. Sarshar, D. Siev, M. M. Mjalli,
Tetrahedron Lett. 1996, 37, 835; c) T. F. Gallagher, G. L. Seibel, S.
Kassis, J. T. Laydon, M. J. Blumenthal, J. C. Lee, D. Lee, J. C.
Boehm, S. M. Fier-Thompson, J. W. Abt, M. E. Soreson, J. M.
Smietana, R. F. Hall, R. S. Garigipati, P. E. Bender, K. F. Erhard, A.
J. Krog, G. A. Hofmann, P. L. Sheldrake, P. C. McDonnell, S.
Kumar, P. R and Young, J. L. Adams, Bioorg. Med. Chem. 1997, 5,
49.
1
For reviews, see: a) R. W. Armstrong, A. P. Combs, P. A. Tempest,
S. D. Brown and T. A. Keating, Acc. Chem. Res. 1996, 29, 123; b) M. 165 14 a) A. Y. Usyatinsky and Y. L. Khmelnitsky, Tetrahedron Lett. 2000,
D. Burke and S. L. Schreiber, Angew. Chem., Int. Ed. 2004, 43, 46.
a) J. G. Lombardino and E. H. Wiseman, J. Med. Chem. 1974,
17,1182; b) T. F. Gallagher, S. M. Fier-Thompson, R. S. Garigipati,
M. E. Sorenson, J. M. Smietana, D. Lee, P. E. Bender, J. C Lee, J. T.
41, 5031; b) S. E. Wolkenberg, D. D. Wisnoski, W. H. Leister, Y.
Wang, Z. Zhao and C. W. Lindsley, Org. Lett. 2004, 6, 1453; c) R. B.
Sparks and A. P. Combs, Org. Lett. 2004, 6, 2473; d) H. A. Oskooie,
Z. Alimohammadi and M. M. Heravi, Heteroatom Chem. 2006, 17,
699; e) H. Zang, Q. Su, Y. Mo, B.-W. Cheng and S. Jun, Ultrason.
2
70
170
10 | Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]